ArticleInternational urogynecology journal2022
Turkish day-to-day impact of vaginal aging questionnaire: reliability, validity and relationship with pelvic floor distress.
Article in International urogynecology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07250490 (Validation of the DIVAS-Q), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Validation of the DIVAS-Q (Day to Day Impact of Vulvovaginal Atrophic Symptoms Questionnaire) A Portuguese Patient-Reported Outcome Measure
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Validation of the DIVAS-Q (Day-to-Day Impact of Vulvovaginal Atrophic Symptoms Questionnaire): a Portuguese patient-reported outcome measure.Journal of patient-reported outcomes · 2026Observational
- Vaginal aging: from concealed symptoms to defined biomarkers.npj aging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisWe aimed to translate the Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire into Turkish, adapt it culturally, and investigate its reliability and validity. Another aim of the study was to examine the relationship between the impacts of vaginal symptoms and pelvic floor symptoms on quality of life (QoL). We hypothesized primarily that the the Turkish DIVA had good internal consistency, test-retest reliability and construct and criterion validity. Our secondary hypothesis was that the effects of vaginal symptoms and pelvic floor symptoms on QoL would be positively related.
methodsA total of 218 postmenopausal women were included. In the reliability analyses, Cronbach α coefficients, item-total correlation coefficients and intraclass correlation coefficients (ICCs) were used. Construct validity was investigated with explanatory and confirmatory factor analyses. Criterion validity and the relationship between the effects of vaginal symptoms and pelvic floor symptoms were examined by Pearson correlation analysis.
resultsWhile the Cronbach's alpha coefficients ranged between 0.87 and 0.96, the item-total score correlation coefficients were 0.60-0.91. ICCs ranged from 0.90 to 0.99. It was found with confirmatory factor analysis that the model fit the data. Moderate-strong correlations (r = 0.47-0.73) were observed between DIVA scores and the scores of other scales (p < 0.001).
conclusionsThe Turkish DIVA is a reliable and valid tool that comprehensively evaluates the impact of vaginal symptoms on women's QoL. The positive relationship between the impacts of vaginal and pelvic floor symptoms on functionality and well-being of women suggests a holistic view in pelvic health care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.